Blog
Two Peptide Companies, One Gets Paid
Picture two businesses selling the exact same vial.
The first one ships from a warehouse. The website says “research use only, not for human consumption.” There’s a dosing calculator on the product page and bacteriostatic water in the cart.
The second one starts with a video visit. A licensed provider talks to the patient, writes a prescription, and a licensed pharmacy fills it. The vial arrives with a label that has the patient’s name on it.
Same molecule. Same box. Completely different business.
The first one loses its merchant account. Not if. When.
The disclaimer doesn’t do what people think it does
There’s a belief in this space that the words “research use only” act like a shield. Put them on the label and you’re selling chemicals, not medicine, so the rules don’t reach you.
Regulators have looked at that argument and said no, repeatedly and in writing. Their reasoning is simple: they look at what you’re actually set up to do. If you sell the vial, and the mixing water, and a chart showing how much to inject, you’re not selling a research chemical. You’re selling a drug, and the sign on the door doesn’t change that.
Think of it like a bar that calls itself a private club to get around the liquor license. Nobody’s fooled by the sign. They’re looking at whether you’re pouring drinks.
The banks read it the same way. That’s the part that catches people by surprise.
Why your processor cares at all
Here’s the thing most merchants don’t realize: your payment processor isn’t just being cautious. It’s under rules of its own.
Visa and Mastercard put pharmacy and prescription businesses in their highest-risk tier, the same shelf as gambling. Any bank that boards you has to register you there, and if it boards a merchant that turns out to be selling prescription drugs without prescriptions, the bank wears it. Fines, penalties, sometimes losing the right to board that category at all.
So when a processor asks you hard questions, it isn’t suspicion. It’s because your file becomes their file.
Which is also why the cheap answer never lasts. Plenty of peptide sellers get a merchant account somewhere. It runs for a few months, then the acquirer takes a closer look and the account closes with the balance held. Starting over every quarter is not a business.
What actually gets you approved
Three things. That’s the whole list.
A real prescription behind every order. Not a form the customer fills out and submits. A licensed provider who actually evaluates the patient, in most states over live video, and writes the script. An online questionnaire by itself is not recognized as a doctor-patient relationship almost anywhere.
A licensed pharmacy filling it. Someone whose license you can point to, whose name is on the label, with the product list to match.
A certification called LegitScript. This is the one people haven’t heard of, and it’s the gate. It’s the health department grade in the restaurant window. A third party checks your licenses, your prescribers, your pharmacy, your website, and every state you ship to, then issues the certification that banks and ad platforms look for. It runs a bit under a thousand dollars to apply and roughly two thousand a year once you’re approved, and review takes about two weeks if your paperwork is in order.
Get those three and you’re not a high-risk gamble anymore. You’re a healthcare business, and healthcare businesses get processed.
The one question to answer first
Before any of it, there’s a question worth being honest with yourself about: can a licensed pharmacy legally compound what you’re selling?
For some products the answer is a clean yes. For several of the best-known peptides it’s currently no, and that list is actively moving as federal rulemaking works through it. It changes by product, and it has changed twice this year.
That’s not a reason to walk away. It’s a reason to find out where your specific product sits before you spend a thousand dollars on a certification application or sign with a processor who didn’t ask.
Where we come in
We place payment processing for prescription-based telehealth and peptide businesses, and we’ll tell you the truth before you spend money.
Send us what you’re dispensing, who’s prescribing, and which pharmacy is filling it. We’ll tell you whether it’s bankable today, what’s missing if it isn’t, and what approval looks like. If the answer is no, you’ll hear that from us too, and you’ll hear it before you’ve paid anybody.
Current as of September 2026. Federal rules on compounded peptides are actively changing; this post reflects the landscape at the time of writing.
Questions about this article or the Guru Brief?
Email marketing@gogurupay.com or call (844) 725-3933.
Guru Pay helps with onboarding, checkups and billing questions, including when you cannot reach your provider, from 8 a.m. to 8 p.m. Eastern. Direct 24/7 technical support is available through your POS provider.
Guru Pay is an Atlanta merchant services team. We help business owners set up, protect and grow the way they get paid, and we write here about what we see working with shops, restaurants and high-risk merchants every week.
Talk it through with our team →
